Alzheimer's disease is a progressive neurological illness that impairs memory, thinking, and day-to-day functioning. Ithas a significant negative influence on people and is becoming a bigger problem for healthcare systems worldwide.Determining Alzheimer's risk levels accurately and promptly is essential for starting early therapies that can decrease thedisease's course and enhance quality of life. Conventional diagnostic techniques, such as clinical assessments and manualbrain imaging analysis, are often laborious, arbitrary, and vulnerable to variation.In this work, we suggest an automatedapproach that uses a state-of-the-art convolutional neural network and the Inception V3 algorithm to categorizeAlzheimer's risk into four groups: Moderately Demented, Very Mild Demented, Mild Demented, and Non Demented.To ensure strong model performance, the system is trained using a dataset of 6,400 MRI images that have beenpreprocessed to improve features and reduce noise. The Inception V3 model is refined to capture minor patterns in brainareas linked to various stages of Alzheimer's disease via transfer learning methods.The suggested model outperformsseveral current deep learning frameworks and conventional diagnostic techniques with an outstanding 98.6% accuracyrate in risk-level categorization. This technology greatly improves dependability and reduces diagnostic delays byautomating the interpretation of complicated medical imaging data, assisting medical practitioners in making wellinformed judgments. This work demonstrates the revolutionary potential of deep learning in Alzheimer's disease riskassessment and early detection, opening the door for scalable, reasonably priced diagnostic tools in clinical practice.
Aakunuri et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: